171 related articles for article (PubMed ID: 19772586)
1. Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study.
Daubin C; Parienti JJ; Fradin S; Vabret A; Ramakers M; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2009 Sep; 9():157. PubMed ID: 19772586
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
[TBL] [Abstract][Full Text] [Related]
3. [Value of serum procalcitonin in diagnosing bacterial lower respiratory tract infections in people with exacerbation of Chronic Obstructive Pulmonary Disease].
Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):389-92. PubMed ID: 16892144
[TBL] [Abstract][Full Text] [Related]
4. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis.
Pfister R; Kochanek M; Leygeber T; Brun-Buisson C; Cuquemelle E; Machado MB; Piacentini E; Hammond NE; Ingram PR; Michels G
Crit Care; 2014 Mar; 18(2):R44. PubMed ID: 24612487
[TBL] [Abstract][Full Text] [Related]
7. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
[TBL] [Abstract][Full Text] [Related]
8. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
9. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.
Boussekey N; Leroy O; Georges H; Devos P; d'Escrivan T; Guery B
Infection; 2005 Aug; 33(4):257-63. PubMed ID: 16091896
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial.
Müller F; Christ-Crain M; Bregenzer T; Krause M; Zimmerli W; Mueller B; Schuetz P;
Chest; 2010 Jul; 138(1):121-9. PubMed ID: 20299634
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin in children admitted to hospital with community acquired pneumonia.
Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease.
Nseir S; Cavestri B; Di Pompeo C; Diarra M; Brisson H; Lemyze M; Roussel-Delvallez M; Durocher A
Respiration; 2008; 76(3):253-60. PubMed ID: 18547944
[TBL] [Abstract][Full Text] [Related]
15. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
[TBL] [Abstract][Full Text] [Related]
19. Early changes of procalcitonin predict bacteremia in patients with intensive care unit-acquired new fever.
Shi Y; DU B; Xu YC; Rui X; DU W; Wang Y
Chin Med J (Engl); 2013; 126(10):1832-7. PubMed ID: 23673095
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
